Clinical trial
Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the…
NCT00012168 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00012168 |
|---|---|
| Title | Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat |
| Official title | Lymphoscintigraphy Assisted Molecular Staging of Head and Neck Cancer |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Genetic, Other, Procedure, Radiation |
| Interventions | isosulfan blue, polymerase chain reaction, immunohistochemistry staining method, lymphangiography, radionuclide imaging, sentinel lymph node biopsy, technetium Tc 99m sulfur colloid |
| Start date | May 1, 1999 |
| Primary completion | Jul 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Mar 11, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: